Skip to content
OpenCapital
Get started

Forte Biosciences FBRX Q4 2024 Annual earnings

Reported March 24, 2025 · Before market open

EPS-$2.45Beat by $2.10
EPS estimate-$4.55

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.92

Versus estimates

Diluted EPS

Q1 2026-$1.24Miss by $0.08Q4 2025-$1.45Miss by $0.03Q3 2025-$0.99Beat by $0.05Q2 2025-$0.96Beat by $0.25Q1 2025-$1.37Miss by $0.48
Q4 2024-$2.45Beat by $2.10

Ask the moment Forte Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Forte Biosciences report Q4 2024 earnings?
Forte Biosciences (FBRX) reported Q4 2024 earnings on March 24, 2025 before market open.
What were Forte Biosciences's Q4 2024 revenue and EPS?
Forte Biosciences reported eps of $-2.45 for Q4 2024.
Did Forte Biosciences beat estimates in Q4 2024?
EPS beat the consensus estimate of $-4.55 by $2.10.
Where can I find Forte Biosciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-046749) directly on SEC EDGAR. The filing index links above go to sec.gov.